Evaluation and Management of Heart Failure Patients

Condition(s) studied

Investigational drug(s) / intervention(s)

registry-no intervention: registry-no intervention After filling the informed consent the patients will be evaluated for clinical history and physical examination by the nurse and a cardiologist. Then, the patients may perform the following test: ECG, Chest X-RAY, Blood test including: complete blood count, renal and liver function, electrolytes, thyroid function, cholesterol, glucose, Troponin and Brain Natriuretic Peptide

Study summary

The investigator is trying to improving our knowledge in the treatment of HF patients, for the purpose of improving their quality of life and reducing hospitalizations. For achieving this the investigator would like to build a registry which will include all the HF patients going an evaluation in the Heart Failure unit or clinic in our facility,

Eligibility

Primary outcome measure(s)

• NP/ pro-BNP from baseline — 10 years
• QT measurements — 10 years
  ECG will be performed at baseline

Trial sites (1)

More Tel-Aviv Sourasky Medical Center trials in Israel

Other trials for the same condition